cultured meat
-
DATABASE (40)
-
ARTICLES (76)
Founded in 1976, KKR is an American private equity firm headquartered in New York City, USA. The company currently oversees investment opportunities in various industries in America, Europe and Asia, ranging from venture capital to hedge funds. As of March 2021, it has $367bn assets under management, with more than 100 companies in their investment portfolio.Its investment portfolio in Asia-Pacific includes major corporations like Panasonic, COFCO Meat and GenesisCare, as well as startups like Gojek. Elsewhere, it has invested in companies like ride-hailing startup Lyft (which has gone for an IPO), historic guitar maker Gibson, and combat sport broadcasting company UFC (Ultimate Fighting Championship).
Founded in 1976, KKR is an American private equity firm headquartered in New York City, USA. The company currently oversees investment opportunities in various industries in America, Europe and Asia, ranging from venture capital to hedge funds. As of March 2021, it has $367bn assets under management, with more than 100 companies in their investment portfolio.Its investment portfolio in Asia-Pacific includes major corporations like Panasonic, COFCO Meat and GenesisCare, as well as startups like Gojek. Elsewhere, it has invested in companies like ride-hailing startup Lyft (which has gone for an IPO), historic guitar maker Gibson, and combat sport broadcasting company UFC (Ultimate Fighting Championship).
Co-founder, CCO of Cocuus
Patxi Larumbe is the Spanish CCO and co-founder at 3D printing food tech and cell-based meat startup Cocuus, where he has worked since he co-founded it in 2017. Before Cocuus, Larumbe founded and directed eight other companies, the majority, like Cocuus, also based in Pamplona, Navarre. During his extensive entrepreneurial career, Larumbe had experience with design and manufacturing in 3D processes, which he used to innovate in Cocuus. Before Cocuus, he was a director at his building materials distribution company, On Clima, for two years, which was preceded by a two-year stint heading up Tohama, an IoT tech developer for Somfy products. Prior to that, he was commercial director for 20 years at building services company Terradisa and also founded its Catalonia offices.From 2000–2013, Larumbe was the founder and board member at Acustica Arquitectonica, an acoustic architectural design company and from 1995–2005, he had the same responsibilities at his hospitality company, Ostatu Zaharra. Other companies he founded were were Render (1990–96), Netcorp Factory (1996–2000) and No Solo Futbol ("Not Just Soccer") (2000–2004). Larumbe studied electronics at first degree level in Pamplona.
Patxi Larumbe is the Spanish CCO and co-founder at 3D printing food tech and cell-based meat startup Cocuus, where he has worked since he co-founded it in 2017. Before Cocuus, Larumbe founded and directed eight other companies, the majority, like Cocuus, also based in Pamplona, Navarre. During his extensive entrepreneurial career, Larumbe had experience with design and manufacturing in 3D processes, which he used to innovate in Cocuus. Before Cocuus, he was a director at his building materials distribution company, On Clima, for two years, which was preceded by a two-year stint heading up Tohama, an IoT tech developer for Somfy products. Prior to that, he was commercial director for 20 years at building services company Terradisa and also founded its Catalonia offices.From 2000–2013, Larumbe was the founder and board member at Acustica Arquitectonica, an acoustic architectural design company and from 1995–2005, he had the same responsibilities at his hospitality company, Ostatu Zaharra. Other companies he founded were were Render (1990–96), Netcorp Factory (1996–2000) and No Solo Futbol ("Not Just Soccer") (2000–2004). Larumbe studied electronics at first degree level in Pamplona.
Co-founder, COO of Cocuus
Daniel Rico Aldaz is the Spanish COO and co-founder at 3D printing food tech and cell-based meat startup Cocuus, where he has worked since he co-founded it in 2017. Before Cocuus, Rico founded an industrial design company, Rico Ingenio, which was established in 2009, where he continues to be a founding partner.His last full-time position before Cocuus was at systems automation company Kaizen for less than a year, where he headed up the technical office. Prior to that, Rico briefly led the computer-to-plate (CTP) and quality control departments at printers Estellaprint. For 15 years, until 2016, Rico was founder at his own industrial design company El Seis Y El Cuatro.Rico’s varied career has also seen him as head designer of children's parks and gyms at Mader Play, as an IT teacher at a worker’s foundation and as both a graphic and an artistic designer in two communication agencies and a lighting company. During his career, Rico has had experience with design and manufacturing in 3D processes, which he used to innovate in Cocuus. Rico did not attend university. He studied music and design at high school.
Daniel Rico Aldaz is the Spanish COO and co-founder at 3D printing food tech and cell-based meat startup Cocuus, where he has worked since he co-founded it in 2017. Before Cocuus, Rico founded an industrial design company, Rico Ingenio, which was established in 2009, where he continues to be a founding partner.His last full-time position before Cocuus was at systems automation company Kaizen for less than a year, where he headed up the technical office. Prior to that, Rico briefly led the computer-to-plate (CTP) and quality control departments at printers Estellaprint. For 15 years, until 2016, Rico was founder at his own industrial design company El Seis Y El Cuatro.Rico’s varied career has also seen him as head designer of children's parks and gyms at Mader Play, as an IT teacher at a worker’s foundation and as both a graphic and an artistic designer in two communication agencies and a lighting company. During his career, Rico has had experience with design and manufacturing in 3D processes, which he used to innovate in Cocuus. Rico did not attend university. He studied music and design at high school.
Green Monday Ventures is the impact investment arm of Green Monday Group founded by longtime Buddhist David Yeung to produce plant-based meat and operate Hong Kong’s first plant-based concept store.Founded in 2012, the Green Monday movement is a social enterprise aimed at promoting sustainable lifestyle concepts like "green food" to address challenges relating to public health, climate change, food security and animal wellbeing. The Hong Kong-based VC was set up in 2013 to focus on investments in alternative protein companies worldwide.
Green Monday Ventures is the impact investment arm of Green Monday Group founded by longtime Buddhist David Yeung to produce plant-based meat and operate Hong Kong’s first plant-based concept store.Founded in 2012, the Green Monday movement is a social enterprise aimed at promoting sustainable lifestyle concepts like "green food" to address challenges relating to public health, climate change, food security and animal wellbeing. The Hong Kong-based VC was set up in 2013 to focus on investments in alternative protein companies worldwide.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
Co-founder of Meatable
Mark Kotter is the Austrian co-founder at Dutch cell-based meat startup Meatable, the first to use pluripotent stem cells and claim a highly scalable culture technology, which was developed by Kotter prior to founding the startup in 2018. He is also founder at his biotech startup, bit.bio, which is based in Cambridge, UK, since 2016, where he applies his cellular technological innovation to human stem cell research and has raised investments totaling $42m. His main full-time position is at the University of Cambridge, where he has worked since 2009. He has spent more than five years as a clinician-scientist in stem cell research and was previously a lecturer in neurosurgery. Kotter also lectures at Paris Descartes University and is a team leader at the UK’s National Institute for Health Research’s Brain Injury MedTech Co-operative. He also founded Myelopathy.org to raise awareness of cervical myelopathy. His past positions were as a research group leader at the Max Planck Institute for Experimental Medicine for one year, and for two years spent at the Medical University of Vienna. Kotter holds two doctorates; one in philosophy from the University of Cambridge and the other in medicine from the University of Graz in Austria. Kotter also holds a master’s in philosophy from the University of Cambridge.
Mark Kotter is the Austrian co-founder at Dutch cell-based meat startup Meatable, the first to use pluripotent stem cells and claim a highly scalable culture technology, which was developed by Kotter prior to founding the startup in 2018. He is also founder at his biotech startup, bit.bio, which is based in Cambridge, UK, since 2016, where he applies his cellular technological innovation to human stem cell research and has raised investments totaling $42m. His main full-time position is at the University of Cambridge, where he has worked since 2009. He has spent more than five years as a clinician-scientist in stem cell research and was previously a lecturer in neurosurgery. Kotter also lectures at Paris Descartes University and is a team leader at the UK’s National Institute for Health Research’s Brain Injury MedTech Co-operative. He also founded Myelopathy.org to raise awareness of cervical myelopathy. His past positions were as a research group leader at the Max Planck Institute for Experimental Medicine for one year, and for two years spent at the Medical University of Vienna. Kotter holds two doctorates; one in philosophy from the University of Cambridge and the other in medicine from the University of Graz in Austria. Kotter also holds a master’s in philosophy from the University of Cambridge.
Founded in Silicon Valley by serial investor and founder of Google Ventures Bill Marris, Section 32 has multiple investment interests with medicine and biotech key amongst them. Marris himself has invested in over 500 companies, with over one-third resulting in IPO or M&A. Fifty of his portfolio companies have exceeded $1bn valuations, including Uber. Section 32 currently has 48 companies in its portfolio. Its most recent investments have included in Canadian remote medicine platform Cover Health’s $43m Series B round and in the $100m Series B round of US cancer detection software C2i Genomics, both in April 2021. In March 2021, it participated in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Founded in Silicon Valley by serial investor and founder of Google Ventures Bill Marris, Section 32 has multiple investment interests with medicine and biotech key amongst them. Marris himself has invested in over 500 companies, with over one-third resulting in IPO or M&A. Fifty of his portfolio companies have exceeded $1bn valuations, including Uber. Section 32 currently has 48 companies in its portfolio. Its most recent investments have included in Canadian remote medicine platform Cover Health’s $43m Series B round and in the $100m Series B round of US cancer detection software C2i Genomics, both in April 2021. In March 2021, it participated in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
The Plantbase Foundation is a non-profit institution run by entrepreneur and impact investor Willem Blom based in The Netherlands. Most of the Plantbase activities are backed by donors. At least 80% of the donations are used to support enterprises that facilitate the shift from animal agriculture to a vegan lifestyle. The foundation has invested in foodtechs involved in the meat, fish and dairy industries; as well as food delivery and apps. Its portfolio includes fast-growing startups like Heura, Meatable, Livekindly and Mission Barns. It also works with investment partners like Kale United, Mile High Vegan Network, Vegan Entrepreneurs Network and GlassWall Syndicate.
The Plantbase Foundation is a non-profit institution run by entrepreneur and impact investor Willem Blom based in The Netherlands. Most of the Plantbase activities are backed by donors. At least 80% of the donations are used to support enterprises that facilitate the shift from animal agriculture to a vegan lifestyle. The foundation has invested in foodtechs involved in the meat, fish and dairy industries; as well as food delivery and apps. Its portfolio includes fast-growing startups like Heura, Meatable, Livekindly and Mission Barns. It also works with investment partners like Kale United, Mile High Vegan Network, Vegan Entrepreneurs Network and GlassWall Syndicate.
Marinya Capital is the family office ofJohn B Fairfax from the Australian Fairfax family, who originally established Fairfax Media, a large media company. Marinya largely invests in property and agricultural businesses but has also made at least two investments in tech startups and in an Australian VC. Its most recent disclosed investments were in the $4.7m July 2021 seed funding round of NovoNutrients, the US-based biotech producer of alt-protein using fermentation and CO2 and other emissions, and in the $55m Series B round of Australia’s premier plant-based brand v2food in 2020.
Marinya Capital is the family office ofJohn B Fairfax from the Australian Fairfax family, who originally established Fairfax Media, a large media company. Marinya largely invests in property and agricultural businesses but has also made at least two investments in tech startups and in an Australian VC. Its most recent disclosed investments were in the $4.7m July 2021 seed funding round of NovoNutrients, the US-based biotech producer of alt-protein using fermentation and CO2 and other emissions, and in the $55m Series B round of Australia’s premier plant-based brand v2food in 2020.
Beyond Investing is a Geneva-based firm investing in early-stage venture capital and equity growth startups mainly in European developed markets. With average investments of €200,000, the firm’s core investment strategy focuses on sustainability with an investment period lasting 5–10 years.The impact investor targets innovative startups involved in vegan, cruelty-free and plant-based alternatives; biotechnologies, foodtech, new materials, clothing and lifestyle sectors. Successful portfolio foodtechs include Mosa Meat, BlueNalu and Shiok Meats.With a team of vegan finance professionals in the US and Europe, Beyond Investing listed the first US Vegan Climate ETF (VEGN) on the New York Stock Exchange in September 2019. The ETF tracks Beyond Investing’s US Vegan Climate Index which covers an index of 495 of the largest-capitalization companies in the US stock market. The ethical investment option aims to exclude stocks in companies with activities that are not aligned with its vegan-themed, cruelty-free and fossil-fuel-free investing ethos.
Beyond Investing is a Geneva-based firm investing in early-stage venture capital and equity growth startups mainly in European developed markets. With average investments of €200,000, the firm’s core investment strategy focuses on sustainability with an investment period lasting 5–10 years.The impact investor targets innovative startups involved in vegan, cruelty-free and plant-based alternatives; biotechnologies, foodtech, new materials, clothing and lifestyle sectors. Successful portfolio foodtechs include Mosa Meat, BlueNalu and Shiok Meats.With a team of vegan finance professionals in the US and Europe, Beyond Investing listed the first US Vegan Climate ETF (VEGN) on the New York Stock Exchange in September 2019. The ETF tracks Beyond Investing’s US Vegan Climate Index which covers an index of 495 of the largest-capitalization companies in the US stock market. The ethical investment option aims to exclude stocks in companies with activities that are not aligned with its vegan-themed, cruelty-free and fossil-fuel-free investing ethos.
China a “positive environment” for uptake of cultured meat, researcher tells Future Food Asia
But for interested cultured meat companies, China-based Chloe Dempsey suggests it would be better to wait, observe and learn more about the market before trying to tap its massive potential
Because Animals: Pioneering cultured meat for pets
The biotech startup is disrupting the pet food processing industry with cell-based food to minimize environmental “pawprints” and promote animal welfare
Meatable: Cell-based meat startup secures $47m Series A for scalable technology
The Dutch startup offers a pioneering technology for quickly scaling cell-based meat production while eliminating the need for animal-derived growth media
Meatable joins Royal DSM to create growth media specific for cell-based meat tech
The R&D between the biotech startup and fellow Dutch nutrition conglomerate could help scale and drive the commercial viability of lab-grown meat
Future Food Asia 2021: Long road ahead for the clean meat industry
Crucial basic research is still needed to ensure the safety, quality, and production efficiency of lab-grown meat. Concerted public and private sector efforts will accelerate progress
Singapore, the place to start and grow a cellular agriculture startup
A country that imports over 90% of its food supply, Singapore has turned to foodtech, including cellular agriculture, to safeguard food security, supported by proactive regulators
Dao Foods unfazed by China tech crackdown, says alternative proteins aligned with state goals
Impact investor Dao Foods expects government support for alternative proteins to come, as it announces second batch of startups, diversifying into fermentation and cell-based proteins
New Food Invest: Growing an alternative protein business in Asia
With more than 4bn people, Asia presents unique opportunities and challenges to alternative protein startups. Four leading entrepreneurs shared their experiences at the recent New Food Invest conference
Do plant-based meat alternatives stand a chance in China, the world's largest meat consumer?
Major food brands and foodtech startups are trying to build their following in a nascent market forecast to grow to nearly $12bn worth by 2023
Cubiq Foods: Bioreactor farms producing the food of tomorrow
Growing appetite for meat alternatives expected to fuel demand for Cubiq’s low calorie, Omega 3-enriched lab-grown fats
Big Idea Ventures Founder Andrew D Ive: Asia will lead cell-based meat innovation
In a wide-ranging interview, the managing general partner of the US- and Singapore-based foodtech investor also expounds on his goal to extend sustainability to the rest of the food sector, combining good returns with doing good
SWITCH Singapore: Alternative protein sure to take off in Asia, with Singapore as innovation hotbed
In an in-depth discussion, food industry experts say products made with alternative protein in hybrid forms could offer the fastest route to commercialization
Dao Foods: Grooming and betting on China's rising alternative protein startups
How can businesses involve Chinese consumers in the environmental cause, even if it isn’t a priority for them? For that, the impact investor-incubator Dao Foods has got its philosophy-led strategy figured out
Biomilq: Creating cell-based mothers’ milk in a lab
With the aim of helping women struggling to breastfeed, Bill Gates-backed Biomilq is disrupting the $45bn baby formula industry developing lab-grown breast milk from mammary epithelial cells
New Food Invest: Plant-based cheese, the next investment boom?
With alt-protein startups experiencing a global funding boom, industry experts and investors share their views about emerging trends in diverse food sectors
Sorry, we couldn’t find any matches for“cultured meat”.
POPULAR DATABASE
